Andrea Boutros Lara Vera Federico Gatto Giuseppe Fornarini Elisa Zanardi
10.3389/fonc.2022.1048526
Front Oncol
2022 Dec 2;12:1048526.
axitinib hypothyroid myopathy hypothyroidism immune-relate adverse event immunotherapy kidney cancer myopathy pembrolizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36530979/
Case Reports
PMC9755843
36530979
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients
2022